SCHEMBL971423

SCHEMBL971423

C[n+]1ccccc1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC22A2 O15244 1/20 0.48
SLC22A1 O15245 1/20 0.48
SLC22A3 O75751 1/20 0.48
SLC6A4 P31645 1/20 0.48
HDAC8 Q9BY41 5/20 0.46
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 3/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
ACHE P22303 4/20 0.38
KMT2A Q03164 2/20 0.38
TSHR P16473 1/20 0.38
HRH1 P35367 1/20 0.38
PDE4D Q08499 1/20 0.38
RAB9A P51151 1/20 0.37
RCE1 Q9Y256 1/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5604381 0.98 SLC22A2 (0.46) SLC22A2SLC22A1SLC22A3SLC6A4HDAC8
Bromide SCHEMBL27947448 0.98 SLC22A2 (0.46) SLC22A2SLC22A1SLC22A3SLC6A4HDAC8
SCHEMBL8653965 0.85 SLC22A2 (0.56) SLC22A2SLC22A1SLC22A3SLC6A4HDAC8
SCHEMBL3719754 0.84 HDAC8 (0.55) SLC22A2SLC22A1SLC22A3SLC6A4HDAC8
SCHEMBL26811749 0.82 MEN1 (0.46) HDAC8KDM4ESMN1; SMN2HTTACHE
SCHEMBL7257365 0.82 HDAC8 (0.41) SLC22A2SLC22A1SLC22A3SLC6A4HDAC8
Hydrochloric Acid SCHEMBL5146726 0.81 HDAC8 (0.52) SLC22A2SLC22A1SLC22A3SLC6A4HDAC8
SCHEMBL5143707 0.81 HDAC8 (0.42) SLC22A2SLC22A1SLC22A3SLC6A4HDAC8
Hydrochloric Acid SCHEMBL5142141 0.79 HDAC8 (0.41) SLC22A2SLC22A1SLC22A3SLC6A4HDAC8
Hydrochloric Acid SCHEMBL11398019 0.76 MAOA (0.48) KDM4EALDH1A1KMT2ATSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116103711-A Forward and reverse pulse electrolytic nickel-phosphorus alloy solution, preparation method, electroplating method and nickel-phosphorus alloy coating 安徽智备工业科技有限公司 2023-05-12 CN claimed
US-8268977-B2 Strongly quenching oligomeric excimer/quencher pairs for detection schemes THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2012-09-18 US claimed
US-20100129820-A1 STRONGLY QUENCHING OLIGOMERIC EXCIMER/QUENCHER PAIRS FOR DETECTION SCHEMES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-05-27 US claimed
US-7423133-B2 Fluorescent glycosides and methods for their use THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2008-09-09 US claimed
US-20040215012-A1 FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2004-10-28 US claimed
WO-2004019002-A2 FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2004-03-04 WO claimed
US-20240074301-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-02-29 US disclosed
US-11825734-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-21 US disclosed
US-20230337521-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed
EP-3476856-B1 METHOD FOR PRODUCING HALOGEN-CROSSLINKED IRIDIUM DIMER AIST (JP) 2023-09-27 EP disclosed
US-20230171979-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF LG DISPLAY CO., LTD. (KR) 2023-06-01 US disclosed
CN-116103711-A Forward and reverse pulse electrolytic nickel-phosphorus alloy solution, preparation method, electroplating method and nickel-phosphorus alloy coating 安徽智备工业科技有限公司 2023-05-12 CN disclosed
US-10947525-B2 Polymer engineered regenerating bioscavengers CARNEGIE MELLON UNIVERSITY (US) 2021-03-16 US disclosed
US-7875607-B2 Neurodegenerative disorders; antiinflammatory agents; antiischemic agents; neuropathic pain; antiepileptic agents; Parkinson's disease; Alzheimer's disease; antidiabetic agents; 3-(6-Hydroxy-2-methyl-3,4,7,8,9,10-hexahydro-7,10-methano-2H -benzo[h]chromen-2-yl)-propionic acid methyl ester AMPERE LIFE SCIENCES, INC. (US) 2011-01-25 US disclosed
US-20100129820-A1 STRONGLY QUENCHING OLIGOMERIC EXCIMER/QUENCHER PAIRS FOR DETECTION SCHEMES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-05-27 US disclosed
US-20090170814-A1 7,8-BICYCLOAKYL-CHROMAN DERIVATIVES EDISON PHARMACEUTICALS, INC. (US) 2009-07-02 US disclosed
US-7423133-B2 Fluorescent glycosides and methods for their use THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2008-09-09 US disclosed
US-7229738-B2 Silver halide photographic light-sensitive material FUJIFILM CORPORATION (JP) 2007-06-12 US disclosed
US-20040215012-A1 FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2004-10-28 US disclosed
WO-2004019002-A2 FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947525-B2 Polymer engineered regenerating bioscavengers BCHE, ACHE, CES2 SLC22A2 4488/4885SLC22A1 4514/4885SLC22A3 4446/4885
US-11825734-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OSBP SLC22A2 972/4885SLC22A1 1126/4885SLC22A3 1009/4885
US-20240074301-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ICOSLG, OCIAD2, OSBP SLC22A2 1449/4885SLC22A1 1626/4885SLC22A3 1217/4885
US-20230337521-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, NR1H2 SLC22A2 2365/4885SLC22A1 2076/4885SLC22A3 2511/4885
US-20100129820-A1 STRONGLY QUENCHING OLIGOMERIC EXCIMER/QUENCHER PAIRS FOR DETECTION SCHEMES PNKP, TK1, WRN SLC22A2 3909/4885SLC22A1 4194/4885SLC22A3 3907/4885
US-20090170814-A1 7,8-BICYCLOAKYL-CHROMAN DERIVATIVES COQ8A, TFAM, CS SLC22A2 924/4885SLC22A1 1031/4885SLC22A3 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.